Quantitative comparison of human parainfluenza virus hemagglutinin-neuraminidase receptor binding and receptor cleavage

Journal of Virology

Volumn 87, Issue 16, 2013, Pages 8962-8970

  Tappert, Mary M ^a   Zachary Porterfield, J ^a   Mehta D'souza, Padmaja ^b   Gulati, Shelly ^a   Air, Gillian M ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN; GLYCOPROTEIN; LIGAND; N ACETYLNEURAMINIC ACID; NEURAMINIDASE RECEPTOR; RECEPTOR; UNCLASSIFIED DRUG; VIRUS HEMAGGLUTININ;

ARTICLE; BINDING AFFINITY; COMPARATIVE STUDY; CONTROLLED STUDY; DISSOCIATION CONSTANT; ENZYME ACTIVITY; LIGAND BINDING; MICHAELIS CONSTANT; NONHUMAN; NUCLEOTIDE SEQUENCE; PARAINFLUENZA VIRUS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RECEPTOR BINDING; SURFACE PLASMON RESONANCE; VIRUS CULTURE;

HN PROTEIN; HUMANS; HYDROLYSIS; KINETICS; PARAINFLUENZA VIRUS 1, HUMAN; PROTEIN BINDING; RECEPTORS, VIRUS; SURFACE PLASMON RESONANCE;

EID: 84881218610     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00739-13     Document Type: Article

References (34)

1. Iorio RM, Glickman RL, Sheehan JP. 1992. Inhibition of fusion by neutralizing monoclonal antibodies to the haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus. J. Gen. Virol. 73(Pt 5):1167-1176.
2. Moscona A, Peluso RW. 1991. Fusion properties of cells persistently infected with human parainfluenza virus type 3: participation of hemagglutinin-neuraminidase in membrane fusion. J. Virol. 65:2773-2777.
3. Portner A, Scroggs RA, Marx PS, Kingsbury DW. 1975. A temperature-sensitive mutant of Sendai virus with an altered hemagglutininneuraminidase polypeptide: consequences for virus assembly and cytopathology. Virology 67:179-187.
4. Miura N, Uchida T, Okada Y. 1982. HVJ (Sendai virus)-induced envelope fusion and cell fusion are blocked by monoclonal anti-HN protein antibody that does not inhibit hemagglutination activity of HVJ. Exp. Cell Res. 141:409-420.
5. Amonsen M, Smith DF, Cummings RD, Air GM. 2007. Human parainfluenza viruses hPIV1 and hPIV3 bind oligosaccharides with alpha2-3linked sialic acids that are distinct from those bound by H5 avian influenza virus hemagglutinin. J. Virol. 81:8341-8345.
6. Suzuki T, Portner A, Scroggs RA, Uchikawa M, Koyama N, Matsuo K, Suzuki Y, Takimoto T. 2001. Receptor specificities of human respiroviruses. J. Virol. 75:4604-4613.
7. Tappert MM, Smith DF, Air GM. 2011. Fixation of oligosaccharides to a surface may increase the susceptibility to human parainfluenza virus 1, 2, or 3 hemagglutinin-neuraminidase. J. Virol. 85:12146-12159.
8. Ferreira L, Villar E, Munoz-Barroso I. 2004. Gangliosides and N-glycoproteins function as Newcastle disease virus receptors. Int. J. Biochem. Cell Biol. 36:2344-2356.
9. Murrell M, Porotto M, Weber T, Greengard O, Moscona A. 2003. Mutations in human parainfluenza virus type 3 hemagglutininneuraminidase causing increased receptor binding activity and resistance to the transition state sialic acid analog 4-GU-DANA (zanamivir). J. Virol. 77:309-317.
10. Palermo LM, Porotto M, Yokoyama CC, Palmer SG, Mungall BA, Greengard O, Niewiesk S, Moscona A. 2009. Human parainfluenza virus infection of the airway epithelium: viral hemagglutinin-neuraminidase regulates fusion protein activation and modulates infectivity. J. Virol. 83: 6900-6908.
11. Merz DC, Prehm P, Scheid A, Choppin PW. 1981. Inhibition of the neuraminidase of paramyxoviruses by halide ions: a possible means of modulating the two activities of the HN protein. Virology 112:296-305.
12. Porotto M, Murrell M, Greengard O, Doctor L, Moscona A. 2005. Influence of the human parainfluenza virus 3 attachment protein's neuraminidase activity on its capacity to activate the fusion protein. J. Virol. 79:2383-2392.
13. Yewdell J, Gerhard W. 1982. Delineation of four antigenic sites on a paramyxovirus glycoprotein via which monoclonal antibodies mediate distinct antiviral activities. J. Immunol. 128:2670-2675.
14. Greengard O, Poltoratskaia N, Leikina E, Zimmerberg J, Moscona A. 2000. The anti-influenza virus agent 4-GU-DANA (zanamivir) inhibits cell fusion mediated by human parainfluenza virus and influenza virus HA. J. Virol. 74:11108-11114.
15. Porotto M, Fornabaio M, Greengard O, Murrell MT, Kellogg GE, Moscona A. 2006. Paramyxovirus receptor-binding molecules: engagement of one site on the hemagglutinin-neuraminidase protein modulates activity at the second site. J. Virol. 80:1204-1213.
16. Lawrence MC, Borg NA, Streltsov VA, Pilling PA, Epa VC, Varghese JN, McKimm-Breschkin JL, Colman PM. 2004. Structure of the haemagglutinin-neuraminidase from human parainfluenza virus type III. J. Mol. Biol. 335:1343-1357.
17. Zaitsev V, von Itzstein M, Groves D, Kiefel M, Takimoto T, Portner A, Taylor G. 2004. Second sialic acid binding site in Newcastle disease virus hemagglutinin-neuraminidase: implications for fusion. J. Virol. 78:3733- 3741.
18. Porotto M, Fornabaio M, Kellogg GE, Moscona A. 2007. A second receptor binding site on human parainfluenza virus type 3 hemagglutininneuraminidase contributes to activation of the fusion mechanism. J. Virol. 81:3216-3228.
19. Bousse T, Takimoto T. 2006. Mutation at residue 523 creates a second receptor binding site on human parainfluenza virus type 1 hemagglutininneuraminidase protein. J. Virol. 80:9009-9016.
20. Alymova IV, Taylor G, Mishin VP, Watanabe M, Murti KG, Boyd K, Chand P, Babu YS, Portner A. 2008. Loss of the N-linked glycan at residue 173 of human parainfluenza virus type 1 hemagglutininneuraminidase exposes a second receptor-binding site. J. Virol. 82:8400- 8410.
21. Wang ZM, Tong LL, Grant D, Cihlar T. 2001. Expression and characterization of soluble human parainfluenza virus type 1 hemagglutininneuraminidase glycoprotein. J. Virol. Methods 98:53-61.
22. Potier M, Mameli L, Belisle M, Dallaire L, Melancon SB. 1979. Fluoro-metric assay of neuraminidase with a sodium (4-methylumbelliferylalpha-D-N-acetylneuraminate) substrate. Anal. Biochem. 94:287-296.
23. Spiro RG. 1960. Studies on fetuin, a glycoprotein of fetal serum. I. Isolation, chemical composition, and physiochemical properties. J. Biol. Chem. 235:2860-2869.
24. Thompson SD, Laver WG, Murti KG, Portner A. 1988. Isolation of a biologically active soluble form of the hemagglutinin-neuraminidase protein of Sendai virus. J. Virol. 62:4653-4660.
25. Mahon PJ, Deng R, Mirza AM, Iorio RM. 1995. Cooperative neuraminidase activity in a paramyxovirus. Virology 213:241-244.
26. 1H NMR spectroscopy. J. Biol. Chem. 263:18253-18268.
27. Spiro RG, Bhoyroo VD. 1974. Structure of the O-glycosidically linked carbohydrate units of fetuin. J. Biol. Chem. 249:5704-5717.
28. Hermentin P, Witzel R, Doenges R, Bauer R, Haupt H, Patel T, Parekh RB, Brazel D. 1992. The mapping by high-pH anion-exchange chromatography with pulsed amperometric detection and capillary electrophoresis of the carbohydrate moieties of human plasma alpha 1-acid glycoprotein. Anal. Biochem. 206:419-429.
29. Portner A. 1981. The HN glycoprotein of Sendai virus: analysis of site(s) involved in hemagglutinating and neuraminidase activities. Virology 115: 375-384.
30. Colman PM, Varghese JN, Laver WG. 1983. Structure of the catalytic and antigenic sites in influenza virus neuraminidase. Nature 303:41-44.
31. Crennell S, Takimoto T, Portner A, Taylor G. 2000. Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase. Nat. Struct. Biol. 7:1068-1074.
32. Lin YP, Gregory V, Collins P, Kloess J, Wharton S, Cattle N, Lackenby A, Daniels R, Hay A. 2010. Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment? J. Virol. 84:6769- 6781.
33. Zhu X, McBride R, Nycholat CM, Yu W, Paulson JC, Wilson IA. 2012. Influenza virus neuraminidases with reduced enzymatic activity that avidly bind sialic acid receptors. J. Virol. 86:13371-13383.
34. Gulati S, Smith DF, Cummings RD, Couch RB, Griesemer SB, St George K, Webster RG, Air GM. 2013. Human H3N2 influenza viruses isolated from 1968 to 2012 show varying preference for receptor substructures with no apparent consequences for disease or spread. PLoS One 8:e66325. doi:10.1371/journal.pone.0066325.